AbbVie Raised Its FY23 Adjusted EPS Guidance From $10.86-$11.06 To $11.19-$11.23 Versus Consensus Of $11.05
Portfolio Pulse from Benzinga Newsdesk
AbbVie has increased its FY23 adjusted EPS guidance from $10.86-$11.06 to $11.19-$11.23, surpassing the consensus of $11.05.
October 27, 2023 | 11:46 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AbbVie's raised FY23 adjusted EPS guidance could potentially lead to a positive market reaction.
AbbVie's raised EPS guidance for FY23 indicates better than expected profitability. This could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100